HMF Intensive

SKU
10431
Dairy Free Gluten Free No FOS Vegan
Your Price CA$61.50
Retail Price
CA$61.50

Healthcare Practitioners

Exclusive Benefits

Healthcare Practitioners receive:

  • Access to practitioner pricing
  • Special offers & promotions
  • Brochures & supporting materials
Set Up an Account Sign In

Non-Practitioners

How To Buy
Clinically-researched probiotic formula
  • Provides 25 billion CFU per daily dose
  • Contains probiotics to supplement the normal intestinal microbiota following antibiotic therapy
  • Helps improve symptoms of irritable bowel syndrome (IBS) such as bloating, satisfaction with bowel habits, and days with pain within 6 weeks

HMF® Intensive provides a combination of probiotics clinically demonstrated to supplement the normal intestinal microbiota following antibiotic therapy and significantly reduce symptoms of irritable bowel syndrome in adults and children over 11 years. Clinical trials have found that supplementation with HMF® Intensive’s probiotic formula supported gastrointestinal health and helped decreased the degree of microflora disruption associated with antibiotic intake.1,2 Additionally, a clinical trial reported that daily supplementation with this probiotic formula for eight weeks significantly improved six measures of IBS symptoms (symptom severity score, abdominal pain, bloating, days with pain, satisfaction with bowel habits, and quality of life).3 Specifically, probiotic intake led to a 22% decrease in days with intestinal discomfort, 32% improvement in satisfaction with bowel habits, and 30% improvement in quality of life scores.3 When compared to placebo values, satisfaction with bowel habits and mean change in symptom severity score significantly improved after six weeks.3

Adults and children 11 years and older

REFERENCES
1.  Madden, JA, Plummer, SF, Tang, J, Garaiova, I, Plummer, NT, Herbison, M, Hunter, JO, Shimada, T, Cheng, L, Shirakawa, T. Int Immunopharmacol. 2005; 5(6): 1091-1097.
2.  Plummer, SF, Garaiova, I, Sarvotham, T, Cottrell, SL, Le Scouiller, S, Weaver, MA, Tang, J, Dee, P, Hunter, J. Int J Antimicrob Agents. 2005; 26(1): 69-74.
3.  Williams, EA, Stimpson, J, Wang, D, Plummer, S, Garaiova, I, Barker, ME, Corfe, BM. Aliment Pharmacol Ther. 2009; 29(1): 97-103